Effects of Imetelstat on CD34+Cells of Patients with Myelofibrosis

被引：0
|
作者：
Wang, Xiaoli [1 ]
Hu, Cing Siang [2 ]
Li, Yan [2 ]
Qiu, Jiajing [2 ]
Lam, Morgan [3 ]
Eng, Kevin [3 ]
Hoffman, Ronald [2 ]
机构：
[1] Ichan Sch Med Mt Sinai, Myeloproliferat Disorders Res Consortium, New York, NY USA
[2] Ichan Sch Med Mt Sinai, Myeloproliferat Disorders Res Consortium, Dept Med, Div Hematol Oncol,Tisch Canc Inst, New York, NY USA
[3] Geron Corp, Menlo Pk, CA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Circulating CD34+cells of primary myelofibrosis patients contribute to myeloid-dominant hematopoiesis and bone marrow fibrosis in immunodeficient mice
    Saito, Noriyuki
    Yamauchi, Takuji
    Kawano, Noriaki
    Ono, Rintaro
    Yoshida, Shuro
    Miyamoto, Toshihiro
    Kamimura, Tomohiko
    Shultz, Leonard D.
    Saito, Yoriko
    Takenaka, Katsuto
    Shimoda, Kazuya
    Harada, Mine
    Akashi, Koichi
    Ishikawa, Fumihiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (02) : 198 - 207
  • [32] Myeloid metaplasia with myelofibrosis: Cytogenetic and FISH demonstration that CD34+cells but not fibroblasts belong to the pathological clone.
    Bilhou-Nabera, C
    Brigaudeau, C
    Clay, D
    Lai, JL
    Brouty-Boye, D
    Vignon, C
    Gharbi, MJ
    Le Bousse-Kerdiles, MC
    Praloran, V
    BLOOD, 2002, 100 (11) : 589A - 589A
  • [33] Enriched Populations of Human Megakaryocytic Cells Affect the Behavior of Myelofibrosis CD34+Cells As Well As Cells Belonging to the MF Supportive Microenvironment
    Lu, Min
    Xia, Lijuan
    Salama, Mohamed E.
    Hoffman, Ronald
    BLOOD, 2018, 132
  • [34] In vitro effects of imatinib on CD34+cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase
    Meng, Fankai
    Zeng, Wen
    Huang, Lifang
    Qin, Shuang
    Miao, Ningning
    Sun, Hanying
    Li, Chunrui
    ONCOLOGY LETTERS, 2014, 7 (03) : 791 - 796
  • [35] Bioactivity of CD34+cells in patients with acute-on-chronic liver failure
    Wu, Yi-Chen
    Wan, Zhi-Hong
    Rong, Yi-Hui
    Zhu, Bing
    Jiang, Qi-Yu
    Liu, Hong-Ling
    Li, Dong-Ze
    Zhao, Jun
    Xing, Han-Qian
    Su, Hai-Bin
    Hu, Jin-Hua
    Xin, Shao-Jie
    Zang, Hong
    You, Shao-Li
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (11): : 10781 - 10791
  • [36] Natalizumab increases circulating CD34+cells with an impaired functional potential in patients with multiple sclerosis. Bone marrow derived CD34+cells remain unaffected
    Saure, C.
    Zohren, F.
    Bruns, I
    Schroeder, T.
    Caddedu, R. P.
    Fischer, U.
    Kobbe, G.
    Hartung, H. P.
    Kieseier, B.
    Haas, R.
    ONKOLOGIE, 2010, 33 : 218 - 218
  • [37] Short- and long-term engraftment of CD34-and CD34+cells from mobilized blood differs from that of CD34-and CD34+cells from marrow.
    Verfaillie, CM
    Almeido-Porada, G
    Wissink, S
    Zanjani, ED
    BLOOD, 1999, 94 (10) : 133A - 133A
  • [38] CD34+cells in hematopoietic stem cell transplantation
    Demirer, T
    TISSUE ENGINEERING, STEM CELLS AND GENE THERAPIES, 2003, 534 : 107 - 118
  • [39] Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis
    Shi, Jun
    Zhao, Yan
    Ishii, Takefumi
    Hu, Wenyang
    Sozer, Selcuk
    Zhang, Wei
    Bruno, Edward
    Lindgren, Valerie
    Xu, Mingjiang
    Hoffman, Ronald
    CANCER RESEARCH, 2007, 67 (13) : 6417 - 6424
  • [40] IMPROVED EXPANSION OF CD34+CELLS AND PROGENITOR CELLS WITH CO-CULTURE OF CD34+CELLS WITH IMMORTALIZED UMBILICAL CORD BLOOD MESENCHYMAL STEM CELLS
    Celebi, B.
    Pineault, N.
    Mantovani, D.
    EXPERIMENTAL HEMATOLOGY, 2010, 38 (09) : S15 - S15
12345